Delivering high value therapies in COPD: the secret is in the marketing
- PMID: 31023865
- DOI: 10.1183/13993003.00215-2019
Delivering high value therapies in COPD: the secret is in the marketing
Conflict of interest statement
Conflict of interest: H. Ashdown reports consultancy fees paid to institution from Boehringer Ingelheim, outside the submitted work. Conflict of interest: M. Steiner reports personal fees for advisory board work, honoraria for speaking engagements, and travel support for meeting attendance from Boehringer Ingelheim and GSK, personal fees for advisory board work from Nutricia, outside the submitted work.
Comment on
-
Interdisciplinary COPD intervention in primary care: a cluster randomised controlled trial.Eur Respir J. 2019 Apr 25;53(4):1801530. doi: 10.1183/13993003.01530-2018. Print 2019 Apr. Eur Respir J. 2019. PMID: 30792342 Clinical Trial.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical